Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

clopidogrel

Known as: Clopidogrelum, clopidogrel [Chemical/Ingredient], methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate 
a kind of anti-clotting drug
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
As a result of the adaptation of life to an aerobic environment, nature has evolved a panoply of metalloproteins for oxidative… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2018
Review
2018
Background and Purpose— The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations for… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2017
Review
2017
Background: The association of genetic polymorphisms and clopidogrel efficacy in patients with ischemic stroke or transient… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2017
Review
2017
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the treatment of choice for the prevention of atherothrombotic… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2016
Review
2016
Chronic constipation affects approximately 16% of the world's population (1), 17.1% of persons in Europe (2), 12% to 19% of those… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more… Expand
  • table 1
  • table 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Clopidogrel requires transformation into an active metabolite by cytochrome P-450 (CYP) enzymes for its antiplatelet… Expand
  • figure 1
  • figure 2
  • table 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Pharmacogenetic determinants of the response of patients to clopidogrel contribute to variability in the biologic… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Dual-antiplatelet therapy with aspirin and a thienopyridine is a cornerstone of treatment to prevent thrombotic… Expand
  • table 1
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 3
Is this relevant?